One Stop Shop for All Your Market Research Reports

United States Injectable Anticoagulants Market by Manufacturers, States, Type and Application, Forecast to 2022

"The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin?], enoxaparin [Lovenox?]) and factor Xa inhibitors (fondaparinux [Arixtra?]). In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism." Scope of the Report: This report focuses on the Injectable Anticoagulants in United States market, to split the market based on manufacturers, states, type and application. Market Segment by Manufacturers, this report covers Sanofi Genentech (Roche) Boehringer Ingelheim Pfizer The Medicines Company Aspen Otsuka Market Segment by States, covering California Texas New York Florida Illinois Market Segment by Type, covers Low-molecular-weight Heparin (LMWH) Direct Thrombin Inhibitor (DTI) Other Market Segment by Applications, can be divided into VTE ACS/MI AF Other There are 17 Chapters to deeply display the United States Injectable Anticoagulants market. Chapter 1, to describe Injectable Anticoagulants Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Injectable Anticoagulants, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Injectable Anticoagulants, for each state, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications; Chapter 12, Injectable Anticoagulants market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 15, to describe sales channel, distributors, traders, dealers etc. Chapter 16 and 17, to describe Injectable Anticoagulants Research Findings and Conclusion, Appendix, methodology and data source.
Table of Contents 1 Market Overview 1.1 Injectable Anticoagulants Introduction 1.2 Market Analysis by Type 1.2.1 Low-molecular-weight Heparin (LMWH) 1.2.2 Direct Thrombin Inhibitor (DTI) 1.2.3 Other 1.3 Market Analysis by Applications 1.3.1 VTE 1.3.2 ACS/MI 1.3.3 AF 1.3.4 Other 1.4 Market Analysis by States
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 4480
Corporate User US $8960
About this Report
Report ID 112477
Category
  • Healthcare
Published on 8-Jun
Number of Pages 122
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(55)